This is an old revision of this page, as edited by Beetstra (talk | contribs) at 14:39, 24 November 2011 (Saving copy of the {{drugbox}} taken from revid 456966867 of page Omeprazole for the Chem/Drugbox validation project (updated: 'DrugBank').). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 14:39, 24 November 2011 by Beetstra (talk | contribs) (Saving copy of the {{drugbox}} taken from revid 456966867 of page Omeprazole for the Chem/Drugbox validation project (updated: 'DrugBank').)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)This page contains a copy of the infobox ({{drugbox}}) taken from revid 456966867 of page Omeprazole with values updated to verified values. |
Clinical data | |
---|---|
License data |
|
Pregnancy category |
|
Routes of administration | Oral, IV |
ATC code | |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Bioavailability | 35–76% |
Protein binding | 95% |
Metabolism | Hepatic (CYP2C19, CYP3A4) |
Elimination half-life | 1 – 1.2 hours |
Excretion | 80% Renal 20% Faecal |
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
Chemical and physical data | |
Formula | C17H19N3O3S |
Molar mass | 345.4 g/mol g·mol |
3D model (JSmol) | |
SMILES
| |
InChI
| |
(what is this?) (verify) |
- Prilosec Prescribing Information. AstraZeneca Pharmaceuticals.
- Vaz-Da-Silva, M; Loureiro, AI; Nunes, T; Maia, J; Tavares, S; Falcão, A; Silveira, P; Almeida, L; Soares-Da-Silva, P (2005). "Bioavailability and bioequivalence of two enteric-coated formulations of omeprazole in fasting and fed conditions". Clin Drug Investig. 25 (6): 391–9. doi:10.2165/00044011-200525060-00004. PMID 17532679.